# EDGAR Filing Document

**Accession Number:** 0001860657
**File Stem:** 0001213900-25-118092
**Filing Date:** 2025-12
**Character Count:** 2501
**Document Hash:** 436b27e40e208d54e3c8c728ec36df06
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-118092.hdr.sgml**: 20260603

**ACCESSION NUMBER**: 0001213900-25-118092

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251204

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Allarity Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001860657
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 24 SCHOOL ST., 2ND FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02108
- **BUSINESS PHONE:** 401-426-4664

**MAIL ADDRESS:**
- **STREET 1:** 24 SCHOOL ST., 2ND FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02108

**VIA EDGAR**

December 4, 2025

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Allarity Therapeutics, Inc.** |
|  | **Registration Statement on Form S-3** |
|  | **File No. 333-291906** |

---

**Acceleration Request**

---

| | |
|:---|:---|
| **Requested Date:** | **December 5, 2025** |
| **Requested Time:** | **4:00 p.m., Eastern Time** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Allarity Therapeutics, Inc. (the "Company") hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced registration statement (the "Registration Statement") to become effective on December 5, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Venable LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel, Venable LLP, by calling William N. Haddad at (212) 503-9812 or, in his absence, Arif Soto at (212) 503-0874.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| ALLARITY THERAPEUTICS, INC. | ALLARITY THERAPEUTICS, INC. |
| By: | /s/ Thomas H. Jensen |
| Name: | Thomas H. Jensen |
| Title: | Chief Executive Officer |

---

cc: William N. Haddad, Venable LLP <br> Arif Soto, Venable LLP